InterVene announced today that it received FDA 510(k) clearance for its Recana thrombectomy catheter system. FDA clearance covers the treatment of venous in-stent restenosis (ISR) and native vessel obstructions. It comes just over a year after the company raised $13 million in its Series A funding round to support Recana. Redwood City, … [Read more...] about InterVene wins FDA 510(k) for Recana thrombectomy catheter
InterVene
InterVene raises $13M to support catheter tech development
InterVene announced today that it raised $13 million in a Series A financing round to support its Recana catheter system. New investor Treo Ventures and existing investor RiverVest Venture Partners co-led the round. In conjunction with the financing, Brad Vale, Treo Ventures founding general partner, joins InterVene's board of … [Read more...] about InterVene raises $13M to support catheter tech development
